Geron to Present at the 14th Annual Needham Healthcare Conference

MENLO PARK, Calif., April 7, 2015 (GLOBE NEWSWIRE) -- Geron Corporation GERN today announced that John Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at the 14^th Annual Needham Healthcare Conference in New York. The presentation is scheduled to occur on Tuesday, April 14, at 5:00 p.m. Eastern Time.

A live webcast of the presentation will be available through the Investor Relations pages of Geron's website or at http://wsw.com/webcast/needham71/gern/. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.

About Geron

Geron is a clinical stage biopharmaceutical company focused on the development of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.